|
|
 |
|
Viewing report
|
|
|
|
Barr Pharmaceuticals, Inc. (Inactive): SWOT Analysis & Company Profile
Business Review, Jan 2011, Pages: 30
Synopsis
Business Review’s Barr Pharmaceuticals, Inc. (Inactive) contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Barr Pharmaceuticals, Inc. (Inactive)’s business.
Business Review’s “Barr Pharmaceuticals, Inc. (Inactive) SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Barr Pharmaceuticals, Inc. (Inactive)) for business intelligence requirements
- Studies and presents Barr Pharmaceuticals, Inc. (Inactive)’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Barr Pharmaceuticals, Inc. (Barr) is engaged in the development, manufacturing and marketing of generic and proprietary pharmaceuticals in generic pharmaceuticals and proprietary pharmaceuticals segments. Also, Barr is into the development and manufacturing of active pharmaceutical ingredients (API). The company’s operations are carried out in almost than 30 countries. Barr’s operations are mainly in North America and Europe. Barr Pharmaceuticals, Inc. markets its products in more than 30 countries, mainly including United States, Canada, Croatia, Germany, Poland and Russia. As on December 2008, the company was acquired by Teva Pharmaceutical Industries Limited. It is headquartered in Montvale, New Jersey, the US.
|
|
|
|
